Agile Medicine Production: From Raw Materials to Patient-Ready Medications:
On Demand Pharmaceuticals provides hospitals with agile 503A and 503B production capabilities, at or near the point of care – tailored to meet your specific needs. Our services include a customizable formulary of sterile injectable medicines and dosage forms, ensuring flexibility in addressing healthcare provider needs. Additionally, our 503A and 503B production capabilities are supported by rapid formulation development and deployment capabilities, small-scale active pharmaceutical ingredient (API) production, and comprehensive quality management systems and sourcing of other raw materials. This innovative approach helps hospitals achieve a more agile and transparent supply chain, ensuring a consistent supply of drugs, predictable pricing, and a significant reduction in drug shortages. With On Demand Pharmaceuticals, hospitals and clinics can enhance their operational efficiency and improve patient care.
Shortage Mitigation
On Demand Pharmaceuticals (ODP) helps mitigate shortages with its agile formulary development and deployment and production capabilities. This is combined with AI/ML-enabled software solutions that provide unique supply chain intelligence and analytics capabilities. Using advanced algorithms, our platform identifies alternative sources of raw materials and helps determine optimal chemical synthesis routes to produce sterile injectable medications.
Fast, Flexible, Reliable
Our distributed production approach offers unmatched speed and adaptability. The Pharmacy on Demand™ (PoD) can be set up at your hospital, central/consolidated services center, or at a site near your hospital. It can even be set up in your hospital if there is space. The formulary can be tailored to your shortage need
Emergency-Ready Medicine Production
When disasters strike, from pandemics to natural catastrophes like hurricanes or floods, the healthcare system often faces severe drug shortages due to supply chain disruptions or sudden surges in demand. On Demand Pharmaceuticals can be a partner during this time of need – producing sterile injectables where and when needed.
Future Services
On Demand Pharmaceuticals’ existing platform will evolve to support new modalities and applications, paving the way for transformative innovations in the production and delivery of medicine.
503A Shortage Response Capability
The 503A Shortage Response Capability focuses on providing tailored, patient-specific medications to address drug shortages efficiently.
- Agile non-sterile to sterile anticipatory production capabilities to meet a wide variety of injectable drug shortage needs
- Standardized, software-driven processes that start from pre-packaged raw materials from vetted cGMP/quality sources
- Deployable over software
- Access to expanded formulary updates
- Terminal sterilization and extended BUD testing available
- Meets or exceeds all USP 797 requirements
Turnkey 503B Health System Capabilities
Turnkey 503B Health System Capabilities offer healthcare organizations a seamless solution for producing high-quality medicines as a service.
- Agile non-sterile to sterile cGMP compliant production capabilities to meet a wide variety of injectable drug needs
- Standardized, software-driven processes that start from pre-packaged raw materials from vetted cGMP/quality sources
- Deployable over software
- Access to expanded formulary updates
- Terminal sterilization and extended BUD testing available
- Meets or exceeds cGMP requirements
Benefits
503A and 503B Capabilities
- Empowers pharmacists to control supply
- Shortage drugs made onsite
- Rapid formulary expansion
- Highly agile production system
- Full transparency into supply chain
- Larger volume 503B production
- Ability to off-set costs through sales of medicines produced, but not needed
- Reduced pricing volatility
- Dependable supply of freshly compounded medicines